Edition:
United States

Revenio Group Oyj (REG1V.HE)

REG1V.HE on Helsinki Stock Exchange

36.03EUR
12:00pm EST
Change (% chg)

€-0.06 (-0.17%)
Prev Close
€36.09
Open
€36.01
Day's High
€36.14
Day's Low
€35.80
Volume
8,675
Avg. Vol
5,247
52-wk High
€41.41
52-wk Low
€28.05

Latest Key Developments (Source: Significant Developments)

Revenio Acquires Minority Interest In Oscare Medical
10:00am EST 

Dec 11 (Reuters) - Revenio Group Oyj ::REG-REVENIO GROUP CORPORATION: REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY.‍SIGNED AN AGREEMENT TO PURCHASE MINORITY INTEREST IN OSCARE MEDICAL OY, A STAKE OF 46.5% IN COMPANY​.‍FOLLOWING TRANSACTION, REVENIO GROUP CORPORATION WILL OWN 100% OF OSCARE MEDICAL OY​.‍REVENIO WILL MAKE IMPAIRMENT-RELATED ENTRIES IN FINANCIAL STATEMENTS FOR 2017​.- ‍ARRANGEMENT AND IMPAIRMENTS WILL HAVE ONE-OFF EFFECT OF AROUND EUR 1.4 MILLION ON OPERATING PROFIT FOR 2017​.‍ARRANGEMENT WILL HAVE NO EFFECT ON REVENIO'S FINANCIAL GUIDANCE FOR CURRENT YEAR.​.  Full Article

Revenio Group Q3 operating proft up at EUR 2.5 mln
Thursday, 26 Oct 2017 02:00am EDT 

Oct 26 (Reuters) - REVENIO GROUP OYJ ::Q3 NET SALES EUR ‍6.4​ MILLION VERSUS EUR 5.8 MILLION YEAR AGO.Q3 OPERATING PROFIT EUR ‍2.5​ MILLION VERSUS EUR 1.9 MILLION YEAR AGO.‍SAYS 2017 NET SALES GROWTH IS EXPECTED TO REMAIN STRONG PROFITABILITY​.  Full Article

Revenio Q2 net sales up at EUR 6.7 ‍​ million
Monday, 7 Aug 2017 02:00am EDT 

Aug 7 (Reuters) - REVENIO GROUP OYJ ::Q2 NET SALES EUR 6.7 ‍​ MILLION VERSUS EUR 5.8 MILLION YEAR AGO.Q2 OPERATING PROFIT EUR ‍​ 2.3 MILLION VERSUS EUR 1.7 MILLION YEAR AGO.SAYS PROFITABILITY IS EXPECTED TO REMAIN AT A HEALTHY LEVEL DESPITE GROWTH INVESTMENTS‍​.  Full Article

Revenio Q1 operating profit up at EUR 1.7 million
Thursday, 20 Apr 2017 02:02am EDT 

April 20 (Reuters) - REVENIO GROUP OYJ :Q1 NET SALES EUR 6.0 MILLION VERSUS EUR 5.2 MILLION YEAR AGO.Q1 OPERATING PROFIT EUR 1.7 MILLION VERSUS EUR 1.3 MILLION YEAR AGO.2017 NET SALES GROWTH IS EXPECTED TO REMAIN STRONG.2017 PROFITABILITY IS EXPECTED TO REMAIN AT A HEALTHY LEVEL DESPITE GROWTH INVESTMENTS.  Full Article

Revenio: FDA marketing approval granted in the US
Wednesday, 22 Mar 2017 03:30am EDT 

Revenio Group Oyj : Icare Finland Oy has received a marketing approval for Icare HOME tonometer in United States. . Received marketing approval does not have an affect on 2017 financial guidance. .Icare will immediately start preparations for launching product in United States..  Full Article

Revenio Q4 operating profit up at EUR 2.1 million
Thursday, 16 Feb 2017 02:00am EST 

Revenio Group Oyj : Q4 net sales 6.6 million euros ($7.00 million) versus 5.5 million euros year ago . Q4 operating profit 2.1 million euros versus 1.2 million euros year ago . Will propose dividend of 0.74 euro per share .Says net sales growth is expected to remain strong in 2017, profitability to remain at healthy level despite growth investments.  Full Article

Revenio Q2 operating profit up at EUR 1.7 million
Monday, 8 Aug 2016 02:07am EDT 

Revenio Group Oyj : Q2 net sales 5.8 million euros ($6.4 million) versus 4.9 million euros year ago . Q2 operating profit 1.7 million euros versus 1.5 million euros year ago .Net sales growth is expected to remain strong.  Full Article

Revenio appoints Timo Hildén new CEO as of Jan 1, 2017
Monday, 16 May 2016 06:00am EDT 

Revenio Group Oyj : New CEO for Revenio and expansion in management team . Has appointed Timo Hildén (born 1959) as new group CEO as of Jan. 1, 2017 . CEO Olli-Pekka Salovaara (born 1960) will leave his position after a transition period on Jan. 1, 2017 .Salovaara will continue in position of executive chairman of board of Icare USA Inc.'s.  Full Article

Revenio Group Oyj: Icare ic100 gets sales permit for US markets
Wednesday, 20 Apr 2016 01:21am EDT 

Revenio Group Oyj:Icare ic100 has received sales permit for the US markets.DA sales permit regards Icare ic100 tonometer.  Full Article

Revenio Group Oyj says FDA did not grant sales permit for Icare HOME in U.S.
Thursday, 17 Mar 2016 03:36am EDT 

Revenio Group Oyj:Says FDA did not grant sales permit for Icare HOME in the U.S.Will publish further inform about impact of negative decision as soon as possible.Says the company's unit, Icare Finland Oy, submitted in September a sales permit application for its Icare HOME tonometer for monitoring eye pressure at home.  Full Article

BRIEF-Revenio Acquires Minority Interest In Oscare Medical

* REG-REVENIO GROUP CORPORATION: REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY